In this study, treatment of HCC cells with curcumin resulted in a dose‐dependent reduction in COPS5 and MK2 expression, as well as inactivation of the MK2‐HSPB1 axis (Figure 8A). This evidence concerns the gene MAPKAPK2 and hepatocellular carcinoma.